一个具有潜在临床实用性的结肠癌子组的脆弱性
Loredana Vecchione1, Valentina Gambino1, Jonne Raaijmakers2
1Division of Molecular Carcinogenesis and Cancer Genomics Center Netherlands, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands.
Cell
|April 9, 2016
概括
研究人员确定RAN结合蛋白2 (RANBP2) 对类似BRAF的结肠癌生存至关重要. 抑制RANBP2导致细胞死亡,这些瘤对潜在的向治疗方法维诺雷尔宾的敏感性增加.
科学领域:
- 癌症学
- 分子生物学
- 遗传学
背景情况:
- BRAF (V600E) 突变性结肠癌与一些非突变性瘤具有共同的基因表达特征,称为"BRAF-like"瘤.
- 类似BRAF的瘤约占所有结肠癌的20%.
- 识别BRAF类CC的特定漏洞对于开发向疗法至关重要.
研究的目的:
- 通过基因查来确定类似BRAF的结肠癌亚型的治疗弱点.
- 调查RANBP2 (NUP358) 在BRAF类CC细胞存活中的作用.
- 探索维诺尔宾作为针对BRAF类CC的向治疗的潜力.
主要方法:
- 使用基于shRNA的基因选,针对BRAF (V600E) 基因.
- 评估了RANBP2对BRAF类和非BRAF类CC细胞存活的关键性.
- 分析了RANBP2抑制对细胞分裂和微管体动态的影响.
- 在体外和体内对BRAF类CCs的敏感性进行了评估.
主要成果:
- 确定RANBP2对于BRAF类CC细胞的生存至关重要,而非非BRAF类CC细胞.
- 抑制RANBP2诱导了线粒细胞缺陷和细胞死亡,特别是在类似BRAF的CC中.
- RANBP2沉默导致了动脉管外生长的减少,导致螺旋的干扰.
- 与非BRAF类CC相比,BRAF类CC对维诺尔宾的敏感性显著增加.
结论:
- 在BRAF类结肠癌中,RANBP2是关键的生存因子.
- 该机制涉及RANBP2在维持适当的微管动力学和线粒细胞进展方面的作用.
- 维诺雷尔宾是一种有前途的向治疗药物,用于BRAF类结肠癌患者.
相关概念视频
Cancer Prevention
8.7K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
8.7K
Cancer Prevention
3.0K
3.0K
Cancer-Critical Genes II: Tumor Suppressor Genes
10.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.0K
Cancer-Critical Genes II: Tumor Suppressor Genes
2.9K
2.9K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
65
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
65
Cancer Survival Analysis
820
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
820


